The U.S. Food and Drug Administration has approved updated COVID-19 vaccines from Pfizer-BioNTech and Moderna, specifically formulated to target the XFG variant for the 2026-2027 season. The decision clears the way for domestic manufacturers to begin distributing the updated shots to healthcare providers.